Personalized Medicine and Drug Delivery Technologies Enhance Future Growth Potential
This analysis provides an overview and advancements in the oral solid dosage formulation industry, including an evaluation of the current industry scenario, competitive landscape, and regulatory landscape. The scope of the analysis is global, focusing on North America (NA), Europe, Asia-Pacific (APAC), the Middle East, and Latin America (LATAM). It identifies the most prevalent and emerging business models supporting industry stakeholders in enhancing their competitiveness and service offerings.
Discussions on key industry drivers and restraints, partnerships, investment and consolidation activities, disruptive technologies, recent excipient advancements, and present and future trends shed light on the industry’s growth potential. Industry use cases will provide brief insights into game-changing participants working toward developing disruptive technologies and patient-centric drugs. The analysis will also help uncover growth opportunities based on megatrends and business models, clinical needs, use cases, market access strategies, and technology trends.
Research Highlights
- Impact of strategic imperatives on the industry
- Growth drivers and restraints
- Oral solid dosage based on API release profile
- R&D pipeline and product innovations
- Small molecule oral dosage market overview
- Small molecule oral solid dosage formulation by therapy area
- Innovations in extended-release dosage forms
- Industry trends and emerging technologies
- Supply chain resilience strategies - focus areas
- Investment trends - Expansion and capability-building initiatives
- Consolidation trends - mergers & acquisitions
- Company benchmarking
- Oral drug delivery solutions & services
- Growth opportunities
